Philippe has a deep understanding of commercial and payer models across the political and economic spectrum. Before launching p-valorem (consulting) and Optichronix (digital therapeutic startup) during his tenure at Pfizer, Philippe held several market access and commercial senior roles during which he: Defined and supervised implementation of marketing & market access, regulatory and clinical development strategies for phase 2 & 3 assets. Launched 10+ medicines, vaccines, and OTC products. Secured reimbursement worldwide for internal medicines, immunology, oncology, hemophilia portfolio, and vaccines. For Women's Health products in the USA, redefined and supervised the execution of evidence generation strategy. Before living in New York, Philippe lived and worked in France and Germany.
You have not backed any projects.
Lets change that!
Discover Projects
No project created yet.
Lets change that!
Discover Projects
No comments on any project yet.
Lets change that!
Discover Projects
No likes on any project yet..
Lets change that!
Discover Projects
No data found.
Lets change that!
Discover Projects
No data found.
Lets change that!
Discover Projects
No data found.
Lets change that!
Discover Projects
No data found.
Lets change that!
Discover Projects
No data found.
Lets change that!
Discover Projects
No project reviewed yet.
Lets change that!
Discover Projects
Important Disclosure: MedStartr.com is a website owned and operated by MedStartr, Inc., which is not a broker-dealer, funding portal or investment advisor; and neither the website nor MedStartr, Inc. participate in the offer or sale of securities. All securities related activity is conducted through Young America Capital, LLC, a registered broker-dealer and member of FINRA/SIPC. No communication, through this website, email or in any other medium, should be construed as a recommendation for any securities offering.